Abstract
Introduction
There is a growing epidemic of obesity in the United States that is a major concern for public health because obesity is a risk factor for cardiovascular disease, diabetes, cancer, and many other diseases that are leading causes of death, disability, and health care expenditure in the United States. Tremendous public investment has been made into finding genetic determinants of obesity, most recently in the form of GWAS (genome-wide association studies). GWAS studies have resulted in the discovery of many associated genetic loci; for instance, the GIANT consortium has discovered or validated a total of 32 SNPs associated with body mass index (BMI) [1, 2] .
While many successes in the genetics of obesity have occurred, the overall assessment of the contribution of GWAS studies to obesity research remains controversial, largely due to the lack of translation of basic scientific discoveries into improved health outcomes for patients. There are several possible reasons for this failure. One is that the overall explained variance of the discovered loci is not high. For instance, only 1-2% of the variance of BMI is explained by the 32 loci found in the GIANT study [1] , and thus most of the genetic variation in obesity remains undiscovered as of yet. However, there are examples in many GWAS studies in which discovered genetic variants, even of small effect, yield new insight into the pathophysiology of disease. For instance, in Type II diabetes (T2D), while only 10% of the disease heritability is accounted for by the set of discovered genetic variants, novel pathways have been discovered with previously-unknown roles in T2D, and the role of ȕ-cell dysfunction in T2D has been highlighted as a result of these studies [3] .
For GWAS of BMI, some of the newlydiscovered variants are in genes expressed in the central nervous system, and key hypothalamic pathways of energy balance are potentially implicated [1] . However, many of the discovered variants are in or near genes that are poorly understood, and the genetic mechanisms of these variants is unknown. In order to translate discovered genetic variants into new therapies or prevention strategies, first molecular and/or physiological mechanisms of each variant needs to be discovered. However, it is difficult to know where to start when exploring potential genetic risk mechanisms, especially when little is known about a gene. One potential strategy is do use data mining of existing data sets in which detailed phenotypic data is available, and use machine learning and/or statistical modeling of this data for hypothesis generation. This strategy has much promise because of the many large, publicly-available data sets available in dbGAP.
However, the set of statistical and computational methods for data analysis is limited. While many powerful and robust methods for GWAS analysis have been developed, the vast majority of methods are unigenic and univariate, as required for the high dimensionality of GWAS data. Notable exceptions include methods for multi-trait analysis [4, 5] , epistatic methods [6] , and pathway-based methods for collapsing association signals for genes or pathways for improved power [7] . However, none of these methods are optimized for finding detailed mechanisms of action for genetic variants that likely involve the combined influence of multiple, interacting phenotypes.
Data Mining Strategy
Two potential multivariate methods for detailed exploration of the physiological mechanisms of discovered genetic variants are Bayesian Networks (BN) and Structural Equation Modeling (SEM). Bayesian Networks (BN) is a machine learning approach for discovering relationships among a set of variables from an observational data set. The advantages of BN learning algorithms are that they are powerful, they produce graphical models that are intuitive and interpretable, and several optimized algorithms and software programs are currently available.
The disadvantages are that they are computationally intensive (NP-Hard), and existing algorithms are not suitable for large data sets without drastic modifications. An additional disadvantage is that the statistical interpretation and level of confidence in whole networks or network features can be difficult to obtain from existing algorithms.
Structural Equation Modeling (SEM), and path analysis in particular, has the same overall goal as BN which is to learn the causal relationships among a set of random variables. However, SEM methods are more focused on assessment of the fit of proposed models rather than searching for or proposing models for a given data set. SEM has several advantages including a sound theoretical basis, several welldeveloped methods and software platforms (such as MPLUS, LISREL, AMOS, and others), accurate model evaluation statistics such as the chi-squared goodness of fit statistic, the root mean squared error of approximation (RMSEA), and many others, and parameter estimates and standard errors for all model parameters that have appropriate Type I errors under the specified model assumptions. SEM also has disadvantages that include a lack of flexibility with regard to variables and models that can be fit, strong distributional assumptions, and a limited number of variables to model before convergence can fail. Therefore, SEM is not appropriate (by design) for data mining.
To overcome the limitations of BN and SEM when used by themselves, namely, the lack of statistical inference properties for BN, and the inappropriateness of SEM for data mining, we thus propose a hybrid BN/SEM approach that overcomes these limitations to create an overall method that is optimal for our purposes. The BN aspects that will be emphasized are the existence of powerful and efficient algorithms to explore model space. The SEM aspects that will be emphasized are the ability to evaluate model uncertainty, provide confidence intervals for model parameters, and in general perform statistical inference of BN-proposed models. We thus propose a two-part strategy in which BN algorithms are used to propose a set of models to test, and SEM modeling is used to evaluate models for further study. We feel that approach may be a powerful and interpretable tool to dissect the genetic effects of risk variants on obesityrelated diseases and conditions. The method demonstrated here will allow investigators to more productively mine the currentlyavailable data sets of genotypes and phenotypes for obesity-related traits in order to discover testable hypotheses for physiological mechanisms by which genetic variants lead to an obesity phenotype. The remainder of this manuscript is organized as follows: we describe the Americo data set that we use to demonstrate this approach, then we detail the steps of the approach including the BN and SEM modeling details, then we give results for three representative networks discovered from the Americo study, and finally we conclude with a discussion.
Materials and Methods

Description of Americo Study
A total of 294 children, aged 7 to 12 years (53% male), were recruited as part of a cross-sectional cohort study examining population differences in metabolic phenotypes among healthy children (no major illnesses or medical diagnoses). Race/ethnicity was determined by the parents of the subjects who could classify their children into either of these categories: African American (AA; n=96), Hispanic American (HA; n=78), European American (EA; n=114), or Bi-racial (n=6). All children were pubertal stage 3 as assessed by a pediatrician according to the criteria of Marshall and Tanner [8] . Informed assent and consent were obtained from children and parents respectively, as approved and regulated by the University of Alabama at Birmingham Institutional Review Board. All measurements were taken between 2004 and 2008 at the University of Alabama at Birmingham General Clinical Research Center (GCRC) and Department of Nutrition Sciences. Phenotypes consisted of anthropometric measurements, insulin, glucose, and lipid measurements, blood pressure, body composition assessed by dual-energy xray absorptiometry (DXA), and physical activity assessed by accelerometer. Details of the study protocol and phenotype collection can be found elsewhere [9, 10] .
Genotyping and Univariate Association Analysis
96 SNPs with validated associations from prior GWAS studies for BMI, hypertension, Type II Diabetes, and other obesity-related traits were selected for genotyping in the Americo sample [2, [11] [12] [13] [14] [15] [16] [17] . We present the association results and discovered networks for three representative SNPs in this study (see Tables  1 and 2) .
DNA was obtained from all study participants and genotyped using Illumina Golden Gate at the UAB Heflin Genotyping Core. Each SNP was individually tested using an additive model for association with each trait, adjusting for age, Tanner stage, sex, racial/ethnic group, and height 2 (for total body fat and total lean mass).
Specific Algorithm
The hybrid Bayesian Network/Structural Equation Modeling (BN/SEM) approach that we have implemented consists of the following steps:
1. For each SNP, find the set of associated traits at a pre-determined p-value threshold (after correcting for covariates). 2. For the SNP, covariates, and associated traits from the previous step, discover the highestscoring network using DEAL (see details below). 3. Export DEAL network to MPLUS and fit network and obtain model diagnostics. 4. If model fit is appropriate, stop. Otherwise, make modifications to network until model fit is adequate.
The entire procedure including data import, univariate association analysis, Bayesian Network discovery using DEAL, export of discovered network to MPLUS, and MPLUS model evaluation, has been implemented in a custom R program which is available upon request. Final models from MPLUS were visualized using Cytoscape (http://www.cytoscape.org).
DEAL Algorithm Details
DEAL is a package for learning Bayesian Networks in the R programming language (http://cran.rproject.org/web/packages/deal/index.html). DEAL uses a Bayesian framework for learning networks of discrete and continuous variables using a conditional Gaussian likelihood with conjugate updating implemented used a heuristic search strategy. Banlists can be used to disallow edges directed into exogenous variables (such as the SNP and the covariates). The "learn" and "autosearch" functions are used for initializing and searching for the best network, respectively, and default prior distributions are used for all variables.
SEM Modeling Details
Structural models were fit in MPLUS (www.statmodel.com) using MLM estimation (i.e. the Satorra-Bentler chi-squared test) which is designed to be robust in the presence of normality deviations in the modeling of continuous traits. All of the endogenous variables were continuous. Covariates that were categorical were coded as dummy variables. Requirements for an acceptable model fit included: non-significant chi-squared goodness of fit statistic at a level of 0.05, RMSEA (root mean square error of approximation) < 0.06, CFI (comparative fit index) > 0.95, SRMR (standardized root mean residual) < 0.08, and model parameters significant at a p<0.1 for most or all of the edges.
If the DEAL-proposed network did not achieve an adequate fit according to the previouslystated criteria, then a series of steps would be taken to modify the model which consisted of 1) adding edges from each covariate to each endogenous variable and then removing covariate edges which are not significant at p<0.1; 2) iteratively adding, removing, or changing the direction of edges between endogenous variables, and checking for an improvement in model fit. Usually step 1) was sufficient to achieve an adequate model fit (adding covariates to the model), but occasionally step 2) was required to achieve an adequate model fit. Typically, the structure proposed by DEAL was for the most part preserved in the final model.
Results
The univariate association results are shown in Table 1 for three representative genetic variants: one associated variant for three different GWAS traits: Type II Diabetes (T2D), body mass index (BMI), and blood pressure/hypertension (BP/HT). Table 1 lists all traits with p<0.05 for the three specific SNPs (rs4402960 in the gene IGF2BP2 for T2D, rs2681492 in the gene ATP2B1 for BP/HT, and rs7561317 in the gene TMEM18 for BMI). Figure 1 shows the final network models for all three SNPs, and the model evaluation details are shown in Table 2 . For model A for rs4402960 for T2D, the final model shows that the SNP has independent genetic mechanisms on each of the associated traits, total lean mass and insulin sensitivity. For model B for rs6281492 for BP/HT, the discovered model shows support for a mechanism in which genetic risk for diastolic blood pressure is mediated by activity level. Finally, model C is the discovered network for the SNP rs7561317 in TMEM18. taat (total abdominal adipose tissue) was removed from the final model because it is highly correlated with saat (r=0.99) and caused difficulties in model fitting in MPLUS. Overall, this model shows support for a mechanism in which the genetic effect of the TMEM18 SNP on BMI is mediated primarily through abdominal adiposity variables, with additional modulation by total lean mass.
These discovered models have important implications for the genetic effect of each SNP on the target trait. For instant, for the SNP rs4402960 for T2D (model A in Figure 1 ), the effect on lean mass appears to be independent of the effect on insulin sensitivity, and thus lean mass may be an off-target or residual effect of the SNP. For the SNP rs6281492 for BP/HT (model B in Figure 1) , the potential mediation of the genetic effect on blood pressure by activity level may point to a physiologic mechanism of genetic action. For the SNP rs7561317 for BMI, abdominal adipose tissue traits (both intra-abdominal and subcutaneous) appear to mediate the genetic effect on BMI, with additional involvement of total lean mass.
While these preliminary results show that the implementation of this hybrid BN/SEM method is feasible, and that structural models that fit the data can be quickly and efficiently discovered, much additional work needs to be accomplished. First, issues of model identifiability and equivalence need to be resolved.
While the discovered models shown in Figure 1 show adequate fit to the data, it is possible that other models may show similarly good results, thus making certain structural features equivocal. An enumeration of equivalent models would be ideal, although this may be impractical for larger models in which the space of potential networks is too large. In addition, simulation studies are needed to more precisely determine the sample size requirements for fitting networks of specific sizes, structures, and levels of complexity, and validation of discovered networks in larger data sets is needed. 
Discussion
We demonstrate a novel computational system that proposes physiological mechanisms of genetic risk for associated variants discovered in GWAS studies using analysis of phenotypically-rich data sets. Our system combines the power of Bayesian Network discovery algorithms for searching over the large set of potential networks, with the statistical rigor of Structural Equation Modeling for assessing adequate model fit. We demonstrate our approach using preliminary results from a candidate SNP study in the Americo data set, a multi-ethnic cross-sectional study of children with detailed obesity-related phenotypes, giving three discovered genetic mechanisms as an illustration of our approach. Our future work on this computational system will include a detailed simulation study to assess the power and sample size requirements for networks of varying complexity, as well as analysis using larger data sets such as MESA, the Multi-Ethnic Study of Atherosclerosis (MESA) SHARe, which is publicly-available through dbGAP (http://www.ncbi.nlm.nih.gov/gap 
